Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alphabet
Biotech
Alphabet's Calico weaves anti-aging deal with China's Mabwell
Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.
Gabrielle Masson
Jun 26, 2025 4:52pm
Sanofi, Lilly, Amarin & more—Chutes & Ladders
Jun 7, 2024 8:30am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
Isomorphic lands deals with Lilly, Novartis worth nearly $3B
Jan 7, 2024 2:43pm
Quantum Alphabet spinoff starts working with AstraZeneca, Sanofi
Jun 23, 2023 9:24am
Aspen takes root with $147M funding for Parkinson's therapy
May 9, 2022 11:28am